However, the differences became significant by comparing COVID-19 symptomatic subgroup with controls (TNFα p = 0.005; GM-CSF p = 0.002), highlighting that more inflammation was detectable in the subjects undergoing a more severe course of the disease. Here, CSF2 is linked to COVID-19.